These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27770548)

  • 1. Identification of Small-Molecule PHD2 Zinc Finger Inhibitors that Activate Hypoxia Inducible Factor.
    Arsenault PR; Song D; Bergkamp M; Ravaschiere AM; Navalsky BE; Lieberman PM; Lee FS
    Chembiochem; 2016 Dec; 17(24):2316-2323. PubMed ID: 27770548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective Tibetan PHD2 binding to p23 links high altitude adaption to altered oxygen sensing.
    Song D; Li LS; Arsenault PR; Tan Q; Bigham AW; Heaton-Johnson KJ; Master SR; Lee FS
    J Biol Chem; 2014 May; 289(21):14656-65. PubMed ID: 24711448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Zinc Finger of Prolyl Hydroxylase Domain Protein 2 Is Essential for Efficient Hydroxylation of Hypoxia-Inducible Factor α.
    Arsenault PR; Song D; Chung YJ; Khurana TS; Lee FS
    Mol Cell Biol; 2016 Sep; 36(18):2328-43. PubMed ID: 27325674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ribosomal chaperone NACA recruits PHD2 to cotranslationally modify HIF-α.
    Song D; Peng K; Palmer BE; Lee FS
    EMBO J; 2022 Nov; 41(22):e112059. PubMed ID: 36219563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl hydroxylase domain protein 2 (PHD2) binds a Pro-Xaa-Leu-Glu motif, linking it to the heat shock protein 90 pathway.
    Song D; Li LS; Heaton-Johnson KJ; Arsenault PR; Master SR; Lee FS
    J Biol Chem; 2013 Apr; 288(14):9662-9674. PubMed ID: 23413029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the catalytic activity of hypoxia-inducible factor-1alpha-prolyl-hydroxylase 2 by a MYND-type zinc finger.
    Choi KO; Lee T; Lee N; Kim JH; Yang EG; Yoon JM; Kim JH; Lee TG; Park H
    Mol Pharmacol; 2005 Dec; 68(6):1803-9. PubMed ID: 16155211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and mRNA expression of HIF-prolyl hydroxylase-2 (phd2) in hypoxia-sensing pathways from Megalobrama amblycephala.
    Wang H; Huang C; Chen N; Zhu K; Chen B; Wang W; Wang H
    Comp Biochem Physiol B Biochem Mol Biol; 2015 Aug; 186():28-35. PubMed ID: 25868626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
    Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
    J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23.
    Song D; Guan W; Coon LM; Al-Kali A; Oliveira JL; Lee FS
    Hypoxia (Auckl); 2019; 7():81-86. PubMed ID: 31853455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrity of the prolyl hydroxylase domain protein 2:erythropoietin pathway in aging mice.
    Li X; Sutherland S; Takeda K; Fong GH; Lee FS
    Blood Cells Mol Dis; 2010 Jun; 45(1):9-19. PubMed ID: 20400342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
    Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
    Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors.
    Wu Y; Jiang Z; You Q; Zhang X
    Bioorg Med Chem; 2017 Aug; 25(15):3891-3899. PubMed ID: 28625716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A knock-in mouse model of human PHD2 gene-associated erythrocytosis establishes a haploinsufficiency mechanism.
    Arsenault PR; Pei F; Lee R; Kerestes H; Percy MJ; Keith B; Simon MC; Lappin TRJ; Khurana TS; Lee FS
    J Biol Chem; 2013 Nov; 288(47):33571-33584. PubMed ID: 24121508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
    Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
    Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues.
    Hong YR; Kim HT; Lee SC; Ro S; Cho JM; Kim IS; Jung YH
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5953-7. PubMed ID: 24042008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.